Physician profile
Xiaofan Mi
NPI 1922591635
$2,681.24
in general payments reported to CMS, 2019-2025
10 companies · $254 in 2025
The $254 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $549 · 2020: $148 · 2021: $385 · 2022: $666 · 2023: $408 · 2024: $270 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $932.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,246.87 | 2019-2024 | Hydrus Microstent, Centurion, Rocklatan |
| Abbvie INC. | $449.59 | 2022-2025 | |
| Glaukos Corporation | $412.16 | 2019-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $152.43 | 2019-2021 | |
| Sight Sciences, INC. | $108.35 | 2023-2025 | Sion Surgical Instrument, Omni Surgical System |
| Eyepoint US, INC. | $106.24 | 2022 | |
| Allergan, INC. | $99.99 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $46.80 | 2019-2020 | |
| Carl Zeiss Meditec USA, INC. | $37.10 | 2023 | Veracity Surgical |
| Tarsus Pharmaceuticals, INC. | $21.71 | 2024 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiaofan Mi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.